These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 14619962)

  • 1. Isoprostanes: more than just mere markers.
    Crankshaw DJ; Rangachari PK
    Mol Cell Biochem; 2003 Nov; 253(1-2):125-30. PubMed ID: 14619962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Isoprostanes, a new substance group in angiology--of future significance?].
    Aghajanian AA; Oguogho A; Sinzinger H
    Vasa; 1997 May; 26(2):65-9. PubMed ID: 9221617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Isoprostanes--new possibility of the oxidative stress estimation].
    Dołegowska B; Chlubek D
    Przegl Lek; 2004; 61(12):1410-4. PubMed ID: 15850339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isoprostanes as a biomarker of lipid peroxidation in humans: physiology, pharmacology and clinical implications.
    Cracowski JL; Durand T; Bessard G
    Trends Pharmacol Sci; 2002 Aug; 23(8):360-6. PubMed ID: 12377577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular biology of the isoprostanes.
    Cracowski JL; Devillier P; Durand T; Stanke-Labesque F; Bessard G
    J Vasc Res; 2001; 38(2):93-103. PubMed ID: 11316945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathophysiology of isoprostanes in the cardiovascular system: implications of isoprostane-mediated thromboxane A2 receptor activation.
    Bauer J; Ripperger A; Frantz S; Ergün S; Schwedhelm E; Benndorf RA
    Br J Pharmacol; 2014 Jul; 171(13):3115-31. PubMed ID: 24646155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular pharmacology and physiology of the isoprostanes.
    Cracowski JL; Durand T
    Fundam Clin Pharmacol; 2006 Oct; 20(5):417-27. PubMed ID: 16968413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isoprostanes - A novel major group of oxidative stress markers.
    Czerska M; Zieliński M; Gromadzińska J
    Int J Occup Med Environ Health; 2016; 29(2):179-90. PubMed ID: 26670350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The isoprostanes: their role as an index of oxidant stress status in human pulmonary disease.
    Morrow JD; Roberts LJ
    Am J Respir Crit Care Med; 2002 Dec; 166(12 Pt 2):S25-30. PubMed ID: 12471085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Isoprostanes and oxidative stress in brain damage in newborns].
    Minghetti L; Bernardo A; Greco A
    Ann Ist Super Sanita; 2001; 37(4):537-43. PubMed ID: 12046223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatty acid oxidation and isoprostanes: oxidative strain and oxidative stress.
    Basu S
    Prostaglandins Leukot Essent Fatty Acids; 2010; 82(4-6):219-25. PubMed ID: 20363116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. F2-isoprostanes as indices of lipid peroxidation in inflammatory diseases.
    Praticò D; Rokach J; Lawson J; FitzGerald GA
    Chem Phys Lipids; 2004 Mar; 128(1-2):165-71. PubMed ID: 15037161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The isoprostanes - unique products of arachidonate peroxidation: their role as mediators of oxidant stress.
    Morrow JD
    Curr Pharm Des; 2006; 12(8):895-902. PubMed ID: 16533158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The neurobiology of isoprostanes and Alzheimer's disease.
    Praticò D
    Biochim Biophys Acta; 2010 Aug; 1801(8):930-3. PubMed ID: 20116452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Isoprostanes: new markers of oxidative stress in human diseases].
    Cracowski JL; Stanke-Labesque F; Souvignet C; Bessard G
    Presse Med; 2000 Mar; 29(11):604-10. PubMed ID: 10776418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pulmonary biology of isoprostanes.
    Janssen LJ; Catalli A; Helli P
    Antioxid Redox Signal; 2005; 7(1-2):244-55. PubMed ID: 15650412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NADPH oxidase-mediated platelet isoprostane over-production in cirrhotic patients: implication for platelet activation.
    Basili S; Raparelli V; Riggio O; Merli M; Carnevale R; Angelico F; Tellan G; Pignatelli P; Violi F;
    Liver Int; 2011 Nov; 31(10):1533-40. PubMed ID: 22093328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. F2-isoprostanes biomarkers of lipid peroxidation: their utility in evaluation of oxidative stress induced by toxic agents.
    Piłacik B; Nofer TW; Wasowicz W
    Int J Occup Med Environ Health; 2002; 15(1):19-27. PubMed ID: 12038860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isoprostanes inhibit vascular endothelial growth factor-induced endothelial cell migration, tube formation, and cardiac vessel sprouting in vitro, as well as angiogenesis in vivo via activation of the thromboxane A(2) receptor: a potential link between oxidative stress and impaired angiogenesis.
    Benndorf RA; Schwedhelm E; Gnann A; Taheri R; Kom G; Didié M; Steenpass A; Ergün S; Böger RH
    Circ Res; 2008 Oct; 103(9):1037-46. PubMed ID: 18802021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isoprostanes: markers and mediators of oxidative stress.
    Montuschi P; Barnes PJ; Roberts LJ
    FASEB J; 2004 Dec; 18(15):1791-800. PubMed ID: 15576482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.